Trial Profile
A case-control study comparing efficacy of denosumab to zoledronate following teriparatide in female subjects with postmenopausal osteoporosis.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Feb 2016
Price :
$35
*
At a glance
- Drugs Denosumab (Primary) ; Zoledronic acid
- Indications Postmenopausal osteoporosis
- Focus Therapeutic Use
- 10 Feb 2016 New trial record